UA79110C2 - Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders - Google Patents
Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders Download PDFInfo
- Publication number
- UA79110C2 UA79110C2 UA20040907893A UA20040907893A UA79110C2 UA 79110 C2 UA79110 C2 UA 79110C2 UA 20040907893 A UA20040907893 A UA 20040907893A UA 20040907893 A UA20040907893 A UA 20040907893A UA 79110 C2 UA79110 C2 UA 79110C2
- Authority
- UA
- Ukraine
- Prior art keywords
- diclofenac
- topical treatment
- based composition
- oropharyngeal cavity
- cavity disorders
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract description 12
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 title abstract description 11
- 229960001259 diclofenac Drugs 0.000 title abstract description 9
- 230000000699 topical effect Effects 0.000 title abstract 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 abstract description 7
- 229960000281 trometamol Drugs 0.000 abstract description 6
- 239000007864 aqueous solution Substances 0.000 abstract description 5
- 150000003839 salts Chemical class 0.000 abstract description 5
- 239000003814 drug Substances 0.000 abstract 1
- 210000000214 mouth Anatomy 0.000 description 13
- 239000007788 liquid Substances 0.000 description 10
- 239000002324 mouth wash Substances 0.000 description 7
- 229940051866 mouthwash Drugs 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000004177 patent blue V Substances 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000008139 complexing agent Chemical class 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- -1 for example Substances 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 201000001245 periodontitis Diseases 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 235000012752 quinoline yellow Nutrition 0.000 description 2
- 239000004172 quinoline yellow Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-M 4-hydroxybenzoate Chemical compound OC1=CC=C(C([O-])=O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-M 0.000 description 1
- 201000008197 Laryngitis Diseases 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 206010028116 Mucosal inflammation Diseases 0.000 description 1
- 201000010927 Mucositis Diseases 0.000 description 1
- 208000025157 Oral disease Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 108010039491 Ricin Proteins 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- YGCFIWIQZPHFLU-UHFFFAOYSA-N acesulfame Chemical compound CC1=CC(=O)NS(=O)(=O)O1 YGCFIWIQZPHFLU-UHFFFAOYSA-N 0.000 description 1
- 229960005164 acesulfame Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 235000019568 aromas Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- XJCRCPKBJWRZAX-UHFFFAOYSA-L disodium;dibenzoate Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1.[O-]C(=O)C1=CC=CC=C1 XJCRCPKBJWRZAX-UHFFFAOYSA-L 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 229920005606 polypropylene copolymer Polymers 0.000 description 1
- 239000004175 ponceau 4R Substances 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- IZMJMCDDWKSTTK-UHFFFAOYSA-N quinoline yellow Chemical compound C1=CC=CC2=NC(C3C(C4=CC=CC=C4C3=O)=O)=CC=C21 IZMJMCDDWKSTTK-UHFFFAOYSA-N 0.000 description 1
- 229940051201 quinoline yellow Drugs 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2002MI000986A ITMI20020986A1 (it) | 2002-05-10 | 2002-05-10 | Composizione a base di diclofenac per il trattamento topico di affezioni del cavo orofaringeo |
| PCT/EP2003/004044 WO2003094905A1 (en) | 2002-05-10 | 2003-04-16 | Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA79110C2 true UA79110C2 (en) | 2007-05-25 |
Family
ID=11449862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA20040907893A UA79110C2 (en) | 2002-05-10 | 2003-04-16 | Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20050100597A1 (zh) |
| EP (1) | EP1503747B1 (zh) |
| JP (1) | JP2005526120A (zh) |
| KR (1) | KR20040111415A (zh) |
| CN (1) | CN1303992C (zh) |
| AR (1) | AR039977A1 (zh) |
| AT (1) | ATE333872T1 (zh) |
| AU (1) | AU2003232480B2 (zh) |
| CA (1) | CA2477773C (zh) |
| DE (1) | DE60307086T2 (zh) |
| DK (1) | DK1503747T3 (zh) |
| EA (1) | EA006165B1 (zh) |
| ES (1) | ES2268402T3 (zh) |
| GE (1) | GEP20063822B (zh) |
| HK (1) | HK1071312A1 (zh) |
| IL (2) | IL163871A0 (zh) |
| IT (1) | ITMI20020986A1 (zh) |
| MX (1) | MXPA04010401A (zh) |
| PL (1) | PL215221B1 (zh) |
| PT (1) | PT1503747E (zh) |
| UA (1) | UA79110C2 (zh) |
| WO (1) | WO2003094905A1 (zh) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20032523A1 (it) | 2003-12-19 | 2005-06-20 | Acraf | Forma di dosaggio per uso orale comprendente un farmaco |
| ITMI20040235A1 (it) * | 2004-02-13 | 2004-05-13 | Therapicon Srl | Preparazione farmaceutica per il cavo orale |
| CN101138544B (zh) * | 2006-09-06 | 2010-09-29 | 上海医药工业研究院 | 双氯芬酸或其盐局部成膜凝胶组合物及其应用 |
| BRPI0717769A2 (pt) | 2006-10-17 | 2013-11-05 | Nuvo Res | Formulação de gel, método para o tratamento da osteoartrite em um indivíduo sofrendo de dor articular, e, uso de diclofenac de sódio |
| US8546450B1 (en) | 2009-03-31 | 2013-10-01 | Nuvo Research Inc. | Treatment of pain with topical diclofenac compounds |
| US8618164B2 (en) | 2009-03-31 | 2013-12-31 | Nuvo Research Inc. | Treatment of pain with topical diclofenac compounds |
| US20120003162A1 (en) * | 2010-06-30 | 2012-01-05 | Mcneil-Ppc, Inc. | Methods of Preparing Non-Alcohol Bioactive Esential Oil Mouth Rinses |
| KR101936192B1 (ko) * | 2010-12-29 | 2019-01-08 | 엘지전자 주식회사 | 공기조화기의 실외기 |
| DE102011111944A1 (de) * | 2011-08-29 | 2013-02-28 | Richard A. Huthmacher | Verwendung von Diclofenac zur Verhinderung und Behandlung grippaler Infekte sowie durch grippale Infekte bewirkter Krankheitssymtome |
| WO2016001643A1 (en) * | 2014-06-30 | 2016-01-07 | Mitochondrial Substrate Invention Limited | Nutrients solutions for enhancement of cognitive function |
| CN104546527A (zh) * | 2014-12-29 | 2015-04-29 | 福建省闽东力捷迅药业有限公司 | 一种含七叶皂苷钠的漱口液及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT370721B (de) * | 1981-02-24 | 1983-04-25 | Ciba Geigy Ag | Verfahren zur herstellung von neuen salzen der 2- (2,6-dichloranilino)-phenylessigsaeure, der |
| EP0373103B1 (de) * | 1988-11-10 | 1993-03-31 | Ciba-Geigy Ag | Flüssige orale Formulierung |
| CA1340994C (en) * | 1989-09-21 | 2000-05-16 | Rudolf Edgar Dr. Falk | Treatment of conditions and disease |
| US5028413A (en) * | 1990-03-21 | 1991-07-02 | Bausch & Lomb Incorporated | Novel fluoride-containing dentifrice |
| IT1243342B (it) * | 1990-07-13 | 1994-06-10 | Farcon Ag | Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria |
| US5972906A (en) * | 1991-07-03 | 1999-10-26 | Hyal Pharmaceutical Corporation | Treatment of mucous membrane disease, trauma or condition and for the relief of pain thereof |
| IT1250636B (it) * | 1991-07-04 | 1995-04-21 | Ricerche Di Schiena Del Dr Mic | Sale del diclofenac, metodo di preparazione e composizioni farmaceutiche che lo contengono. |
| US5626838A (en) * | 1995-03-13 | 1997-05-06 | The Procter & Gamble Company | Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx |
| CN1059797C (zh) * | 1995-11-22 | 2000-12-27 | 王树力 | 双氯芬酸钠喷雾剂 |
-
2002
- 2002-05-10 IT IT2002MI000986A patent/ITMI20020986A1/it unknown
-
2003
- 2003-04-16 JP JP2004502991A patent/JP2005526120A/ja active Pending
- 2003-04-16 PT PT03749856T patent/PT1503747E/pt unknown
- 2003-04-16 UA UA20040907893A patent/UA79110C2/uk unknown
- 2003-04-16 CN CNB038105764A patent/CN1303992C/zh not_active Expired - Fee Related
- 2003-04-16 WO PCT/EP2003/004044 patent/WO2003094905A1/en active IP Right Grant
- 2003-04-16 PL PL371426A patent/PL215221B1/pl unknown
- 2003-04-16 CA CA2477773A patent/CA2477773C/en not_active Expired - Fee Related
- 2003-04-16 AU AU2003232480A patent/AU2003232480B2/en not_active Ceased
- 2003-04-16 EP EP03749856A patent/EP1503747B1/en not_active Expired - Lifetime
- 2003-04-16 ES ES03749856T patent/ES2268402T3/es not_active Expired - Lifetime
- 2003-04-16 IL IL16387103A patent/IL163871A0/xx active IP Right Grant
- 2003-04-16 KR KR10-2004-7014564A patent/KR20040111415A/ko active IP Right Grant
- 2003-04-16 US US10/505,178 patent/US20050100597A1/en not_active Abandoned
- 2003-04-16 DE DE60307086T patent/DE60307086T2/de not_active Expired - Lifetime
- 2003-04-16 DK DK03749856T patent/DK1503747T3/da active
- 2003-04-16 EA EA200401090A patent/EA006165B1/ru not_active IP Right Cessation
- 2003-04-16 MX MXPA04010401A patent/MXPA04010401A/es unknown
- 2003-04-16 AT AT03749856T patent/ATE333872T1/de active
- 2003-04-16 GE GE5669A patent/GEP20063822B/en unknown
- 2003-05-08 AR ARP030101608A patent/AR039977A1/es not_active Application Discontinuation
-
2004
- 2004-09-01 IL IL163871A patent/IL163871A/en unknown
-
2005
- 2005-05-24 HK HK05104340A patent/HK1071312A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2477773C (en) | 2011-01-18 |
| EA006165B1 (ru) | 2005-10-27 |
| DE60307086D1 (de) | 2006-09-07 |
| AU2003232480A1 (en) | 2003-11-11 |
| IL163871A (en) | 2007-10-31 |
| EA200401090A1 (ru) | 2005-02-24 |
| EP1503747A1 (en) | 2005-02-09 |
| ES2268402T3 (es) | 2007-03-16 |
| DK1503747T3 (da) | 2006-11-27 |
| WO2003094905A1 (en) | 2003-11-20 |
| IL163871A0 (en) | 2005-12-18 |
| PT1503747E (pt) | 2006-11-30 |
| PL215221B1 (pl) | 2013-11-29 |
| MXPA04010401A (es) | 2005-02-17 |
| ITMI20020986A0 (it) | 2002-05-10 |
| ATE333872T1 (de) | 2006-08-15 |
| CA2477773A1 (en) | 2003-11-20 |
| US20050100597A1 (en) | 2005-05-12 |
| AU2003232480B2 (en) | 2008-07-31 |
| WO2003094905A8 (en) | 2004-04-01 |
| DE60307086T2 (de) | 2007-02-01 |
| CN1652763A (zh) | 2005-08-10 |
| PL371426A1 (en) | 2005-06-13 |
| KR20040111415A (ko) | 2004-12-31 |
| EP1503747B1 (en) | 2006-07-26 |
| GEP20063822B (en) | 2006-05-10 |
| CN1303992C (zh) | 2007-03-14 |
| JP2005526120A (ja) | 2005-09-02 |
| HK1071312A1 (en) | 2005-07-15 |
| ITMI20020986A1 (it) | 2003-11-10 |
| AR039977A1 (es) | 2005-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2248015T3 (es) | Composiciones orales que comprenden una sal de potasio para reducir la sensibilidad del nervio central y de la dentina. | |
| CA1066622A (en) | Tooth preparations | |
| BR112018005747B1 (pt) | Composição para higiene bucal compreendendo um aminoácido básico em forma livre ou de sal | |
| UA79110C2 (en) | Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders | |
| US5906810A (en) | Formulations and uses thereof in the prevention and treatment of oral lesions | |
| US20240050334A1 (en) | Oral Care Compositions and Methods | |
| US11090259B2 (en) | Effervescent tablet | |
| CN108245552A (zh) | 一种用于口腔的组合物及其应用 | |
| ES2312921T3 (es) | Disolucion acuosa concentrada de ambroxol. | |
| ES2318277T3 (es) | Composicion farmaceutica que compresnde acido 5-metil-2-(2'-cloro-6'-fluoroanilino)fenilacetico. | |
| ES2732729T3 (es) | Composiciones farmacéuticas acuosas tópicas orales de flurbiprofeno y dexpantenol | |
| US5540913A (en) | Formulations and uses thereof in the prevention and treatment of oral lesions | |
| JPH11246513A (ja) | アズレン水性液剤 | |
| BRPI0417809B1 (pt) | forma de dosagem oral farmacêutica | |
| ES2347257T3 (es) | Enjuague bucal. | |
| PT1312355E (pt) | Composicoes farmaceuticas nao-efervescentes soluveis em agua compreendendo drogas anti-inflamatorias nao-esteroides | |
| ES2200323T3 (es) | Preparacion farmaceutica que contiene nimesulida para administracion por via oral. | |
| RU2524631C2 (ru) | Изменение цвета содеращих халкон препаративных форм по уходу за ротовой полостью | |
| ES2652649T3 (es) | Composiciones farmacéuticas acuosas tópicas de flurbiprofeno y clorhexidina | |
| WO2022220044A1 (ja) | 口腔用組成物 | |
| ES2212983T3 (es) | Composicion terapeutica acuosa que contiene un compuesto de hexahidro-5-pirimidinamina y un alcohol graso polialcoxilado. | |
| EP4387580A1 (en) | Oral care compositions comprising guanidine and stannous ion source and methods | |
| AU2022351151A1 (en) | Oral care compositions and methods of use | |
| BG61892B2 (bg) | Състав на основата на ибупрофен за орална употреба |